Efficacy subgroup analyses in different tumor types.

Abbreviations: PFS: progression free survival; OS: overall survival; ORR: overall response rate; HR: hazard ratio; RR: relative risk; BV: bevacizumab; NSCLC: non-small cell lung cancer.Efficacy subgroup analyses in different tumor types.缩略语：PFS为无进展生存期（Progression Free Survival），OS为总生存期（Overall Survival），ORR为总缓解率（Overall Response Rate），HR为风险比（Hazard Ratio），RR为相对风险（Relative Risk），BV为贝伐珠单抗（Bevacizumab），NSCLC为非小细胞肺癌（Non-Small Cell Lung Cancer）。不同瘤种的疗效亚组分析。